LVAD conditioning to help your heart recover
Part of Heart & circulation clinical trials.
This study looks at an approach called “conditioning” using your LVAD (a heart pump) while you wait for a transplant. It aims to see whether your heart muscle may recover better during planned changes in support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure and are scheduled to get an LVAD (a heart pump) as a bridge to transplant
- You are already enrolled in the related study called “Effects of Mechanical Unloading on Myocardial Function and Structure” (IRB 30622)
- You (or your representative) are willing to sign written consent to join the study
- You had no serious side effects that required hospitalization during the best/“optimum” unloading period
- You may be entering a later “controlled reloading” phase only if you stayed stable during that optimum period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device or procedure to help people with heart failure and a weak heart pump. If you have a low ejection fraction and are on standard medications, you may be able to join.
This trial tests whether injecting special cells (cell therapy) can help the heart recover in people with advanced heart failure who are getting a mechanical heart pump (LVAD). It may offer a new way to improve heart function and quality of life.
This trial tests whether patients with recently implanted heart pumps (LVADs) can safely exercise at home via video calls instead of traveling to a hospital gym. The goal is to help improve fitness and heart function without requiring in-person visits.
This study tests a home exercise program using your smartphone after you get a HeartMate 3™ LVAD. It aims to help you get stronger and recover safely at home.
This study tests whether a small sensor (CardioMEMS) implanted in the lung artery can help doctors better manage LVAD settings and reduce hospital visits. It is for people who already have a HeartMate 3 heart pump and are stable enough to go home.
This study is looking at a new treatment for people with heart failure where the heart’s pumping strength is not reduced much (HFpEF or HFmrEF), but pressure inside the heart is high during exercise. It may help relieve symptoms in people who still feel unwell during normal activity despite stable standard treatment.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.